Prior authorization exists to protect medical necessity and keep utilization grounded. Yet it has become one of the clearest signals of healthcare operations carrying friction at scale.

Most teams experience the process as an endless stream of requests that rarely arrive in a consistent format. Clinical context is scattered across structured EMR fields, scanned documents, PDFs, and handwritten notes. Policy criteria are lengthy, distributed across sources, and difficult to apply quickly. Reviewers spend substantial time reconstructing the clinical story and creating documentation that will hold up later. These steps shape speed, consistency, and defensibility far more than the final determination itself.

What the System Is Telling Us

The scale shows why prior authorization has moved from a workflow issue to a leadership challenge. In Medicare Advantage, prior authorization touches nearly every enrollee, with 99% requiring to obtain approval for at least some services. The operational load lands on clinical and administrative teams. Physicians handle an average of 43 prior authorization requests per week and spend about 12 hours completing them.

Patients experience that drag directly. Delayed access affects 94% of patients requesting prior authorization, and treatment abandonment is reported at 78%. Administrative waste compounds the problem. Prior authorization still relies heavily on manual channels such as faxes, phone calls, and web portals, and the administrative burden is estimated at $35B annually.

Denials and appeals reveal the massive churn the system creates. In 2023, Medicare Advantage insurers denied 3.2 million requests, representing 6.4% of submissions, and 81.7% of denials were fully or partially overturned on appeal. That overturn rate points to repeated work across the same clinical facts. It also highlights the cost of inconsistent decision trails and documentation.

CMS-0057-F Turns Expectations Into Deadlines

Regulatory expectations now tighten the operating envelope under the CMS-0057-F Final Rule. Expedited requests are expected to be handled within 72 hours and standard requests within 7 calendar days. Denial communication is expected to be more explicit through electronic processes, including partial approvals. Public reporting expands accountability, with initial scorecard metrics due by March 31, 2026.

Interoperability requirements reinforce the same direction. A HL7 FHIR API for prior authorization is required by January 1, 2027. The industry is expected to save an estimated $15 to 16B over 10 years through reduced administrative tasks and more efficient processing of requests. That projection signals the scale of waste that becomes removable when operating models modernize.

This changes the leadership conversation. Turnaround time becomes measurable, documentation quality improves compliance and audit exposure, and consistency gets visibility in reporting and appeal patterns.

Prior Authorization Intelligence as an Operating Model

Many organizations have tried to improve prior authorization through staffing, templates, routing, and queue management. Those investments can help early. They often stall when evidence remains messy, criteria are hard to retrieve, and documentation is manual.

Prior authorization intelligence addresses those constraints through a workflow-led operating model.

It starts by making clinical evidence usable early. Optical character recognition and large language models can extract and organize clinical details into structured, chronological summaries that reviewers can use immediately. It then brings policy criteria into the workflow through retrieval that links policy content to diagnosis and procedure codes, so reviewers can evaluate rather than search. It supports the decision moment through reviewer-first decision scaffolding. A copilot can flag eligibility, draft a rationale, and link evidence back to criteria while keeping the reviewer accountable for the final decision.

It also reduces rework through early validation. Matching structured clinical data with incoming request data helps catch mismatches early and reduces downstream loops.

The goal is simple: fewer loops, clearer evidence, more consistent documentation, and stronger defensibility.

Real Result Delivered by Coditas

Coditas delivered this approach for a health tech provider operating large-scale prior authorization workflows. Their client teams worked with fragmented records, complex policy documentation, and high rework costs tied to validation mismatches.

We implemented a GenAI-powered decision support copilot tailored to the reviewer workflow. Evidence was structured into chronological summaries. Policy criteria were retrieved in context. The copilot mapped evidence to criteria and drafted a rationale. Reviewers retained full ownership of final decisions. Validation workflows cross-checked data early, reducing avoidable loops.

The outcomes were measurable:

• Review time is reduced by 70%
• Processing errors decreased by 40%
• Reviewer throughput increased 4x

The pilot moved into production in under 30 days through a modular rollout that avoided disruption to clinical workflows. This is what workflow-led GenAI delivers. Speed improves through clarity and structure, while decision ownership remains with clinicians and reviewers.

What Leaders Must Do Next

The path forward is practical and measurable.

• Start by identifying where time is lost, as in most organizations, delay clusters around evidence extraction, policy navigation, and validation rework
• Standardize the review artifact so every case starts with a consistent clinical story
• Operationalize policy knowledge so criteria are retrievable in context
• Treat rationale as a workflow output so documentation is produced during the decision
• Bring validation forward so mismatches are caught early
• Align the operating model to CMS-0057-F timelines, reporting expectations, and the 2027 interoperability baseline

This is how cycle time improves while documentation remains defensible.

Want the deep dive?

Get the full whitepaper for detailed insights into the prior authorization intelligence and its roadmap aligned to 2026 and 2027 requirements.

Read the full white paper

Coditas will be presenting at HIMSS26. Connect with us to discuss what prior authorization intelligence looks like in your environment and what it takes to move from early value to repeatable performance.